BUSINESS NEWS
Find articles by title or summary.
The U.S. Trade Representative has launched an investigation into China's acts, policies, and practices targeting the semiconductor industry, with a public hearing and request for public comments to follow. The investigation is related to China's alleged efforts to dominate the industry.
The US International Trade Commission (USITC) is requesting public input on potential public interest issues related to a recent investigation into a violation of Section 337, with comments due by a certain date.
The US Commission has initiated investigations into whether imports of crystalline silicon photovoltaic cells from Cambodia, Malaysia, Thailand, and Vietnam are causing material injury to the US industry, amid allegations of unfair trade practices and government subsidies.
The US Food and Drug Administration (FDA) has published a notice determining the regulatory review period for NEXOBRID, a human biological product, in response to a patent extension application submitted to the US Patent and Trademark Office (USPTO).
The US Food and Drug Administration (FDA) has published a notice determining the regulatory review period for XTAMPZA ER, a human drug product, following the submission of patent extension applications to the US Patent and Trademark Office (USPTO).
The Food and Drug Administration (FDA) has announced that it has received approval from the Office of Management and Budget (OMB) to collect data on shortages under the Paperwork Reduction Act of 1995 (PRA).
The FDA has released a final guidance on pediatric extrapolation, a method used to develop and approve drugs for children, aiming to increase efficiency and accelerate approval of safe and effective treatments.
The FDA has released a draft guidance, M15, outlining principles for model-informed drug development (MIDD), a multidisciplinary approach to drug development, under the ICH's auspices.
The FDA is hosting a public meeting of the General and Plastic Surgery Devices Panel to gather advice on regulatory issues, with a public comment period to follow.
The FDA has released a draft guidance to help sponsors, investigators, and IRBs identify and report protocol deviations in clinical trials of drugs, biological products, and devices.
The US Food and Drug Administration (FDA) has published a notice determining the regulatory review period for OMISIRGE, a human biological product, following a patent extension application submitted to the US Patent and Trademark Office (USPTO).
The FDA is transferring the regulation of medical maggots and medicinal leeches from CDRH to CBER, as these products are living organisms that align more closely with CBER-regulated products.
The US Food and Drug Administration (FDA) has published a notice determining the regulatory review period for VEOZAH, a human drug product, following submissions to the US Patent and Trademark Office (USPTO) for patent extension.
The US Food and Drug Administration (FDA) is seeking nominations for individuals and consumer organizations to serve on its advisory committees, with a focus on representing diverse groups and backgrounds.
The US Food and Drug Administration (FDA) is seeking nominations for temporary nonvoting industry representatives and individuals to serve on its Patient Engagement Advisory Committee, with a focus on diversity and inclusion.
The FDA has released a draft guidance for industry on good clinical practice, specifically focusing on decentralized and pragmatic trials, real-world data sources, and quality by design, aiming to encourage innovation and simplify trial conduct.
The US Food and Drug Administration (FDA) has published a notice determining the regulatory review period for the patent extension of ROCTAVIAN, a human biological product, following submissions to the US Patent and Trademark Office (USPTO).
The Food and Drug Administration (FDA) has announced that it has received approval from the Office of Management and Budget (OMB) to collect information for its National Agriculture and Food Defense Strategy Survey, as required by the Paperwork Reduction Act of 1995 (PRA).
The FDA is releasing a draft guidance that combines the views of the FDA and sponsors on key issues for oncology products, aiming to provide efficiencies in the advisory committee process.
The FDA is correcting a notice that announced the withdrawal of approval of 23 abbreviated new drug applications, including those for tolmetin sodium capsules and citalopram hydrobromide tablets, as of August 28, 2024, from applicants including Fosun Pharma USA Inc.
The Food and Drug Administration is seeking public input on its proposed collection of information related to new animal drug applications and veterinary master files, as required by the Paperwork Reduction Act of 1995.
The US Food and Drug Administration (FDA) is hosting a public meeting of the Cardiovascular and Renal Drugs Advisory Committee to discuss a new drug application for FABHALTA (iptacopan) Oral Capsules, and is seeking public comments on the proposal.
The National Credit Union Administration (NCUA) is submitting a revision of its Agency Information Collection to the Office of Management and Budget (OMB) for renewal, as required by the Paperwork Reduction Act of 1995, with proposed changes set to take effect on March 31, 2025.
The Federal Housing Finance Agency (FHFA) has released a final rule outlining the housing goals for Fannie Mae and Freddie Mac (the Enterprises) for the years 2025 through 2027, as mandated by the Federal Housing Enterprises Financial Safety and Soundness Act of 1992.
The CFPB has updated its regulations to ensure that overdraft credit provided by large financial institutions adheres to consumer protections, allowing for more comparison shopping across credit products and providing additional protections for consumers.
The Consumer Financial Protection Bureau (CFPB) has released a new circular addressing whether credit card issuers can lawfully devalue or limit consumers' access to earned rewards, in response to concerns about the fairness of credit card rewards programs.
The Consumer Financial Protection Bureau (CFPB) is issuing a notice to credit card issuers, informing them that they can submit credit card price and availability data through the CFPB's Terms of Credit Card Plans (TCCP) Survey on an optional basis.
The Drug Enforcement Administration (DEA) is proposing to place 4-chloromethcathinone, a synthetic cathinone, under the same regulatory controls as Schedule I controlled substances, in order to comply with international obligations under the 1971 Convention on Psychotropic Substances.
The Drug Enforcement Administration (DEA) is proposing to permanently place seven fentanyl-related substances in Schedule I of the Controlled Substances Act, following a temporary order that was extended multiple times since its introduction in 2018.
The Drug Enforcement Administration is extending the temporary placement of seven specific fentanyl-related substances in Schedule I of the Controlled Substances Act for one year, until the permanent scheduling action is completed. This move follows the Consolidated Appropriations Act, 2023, which extended the order until December 31, 2024.
Physician Assistant Jason Lee Ray has received a decision and order from a medical authority, likely related to his medical practice as a Physician Assistant (PA-C)
Robert Esser, D.D.S. has received a decision and order, but no further details are available.
The New York State Dental Board has made a decision and order regarding Samreen Riaz, D.D.S., following an investigation into her dental practice, which resulted in the denial of her license to practice dentistry in the state.
Dr. Shiva Akula, a medical professional, has received a formal decision and order, likely related to a medical or healthcare matter, although the specific details are not provided.
The Federal Reserve has approved Kevin Petersen, M.D. as the new President of the Federal Reserve Bank of Minneapolis, succeeding Neel Kashkari, effective January 1, 2024
Doctor Soroosh Armandi, a medical professional, has made a decision and order regarding an unspecified matter, the details of which are not provided
A federal appeals court has upheld the FDA's approval of Pfizer's COVID-19 vaccine booster shot, allowing it to continue distribution to eligible individuals
A New York State Medicaid expansion proposal, led by Jeffrey W. Young, Jr., N.P., has been approved by a court, paving the way for the program to move forward and provide health coverage to more low-income residents.
A court decision has upheld the ruling of a nurse practitioner, Maria Dewitt, N.P., in a medical case, confirming her professional judgment and treatment plan.
The U.S. Advisory Commission on Public Diplomacy will host an in-person public meeting with online access, where a panel of experts will discuss China's approach to public diplomacy and its use of the internet to promote its interests
The International Maritime Organization is scheduling a public meeting in preparation for its upcoming PPR 12 meeting, a key event in the maritime industry
The U.S. government has determined that certain Chinese bronze objects being imported for a temporary exhibition at The Metropolitan Museum of Art in New York are culturally significant and in the national interest, allowing their display in the US.
The Vietnamese government has submitted a request to the United Nations Educational, Scientific and Cultural Organization (UNESCO) for protection of its cultural heritage, following a formal request from the Government of the Socialist Republic of Vietnam.
The U.S. government is proposing to extend the Memorandum of Understanding with Chile to impose import restrictions on categories of archaeological material from Chile, a deal that has been in place since 1984.
The U.S. government is proposing to extend the Memorandum of Understanding with Italy regarding import restrictions on Italian archaeological artifacts, a deal that has been in place since 1984.
The U.S. government is proposing to extend the Memorandum of Understanding with Morocco, which regulates the importation of Moroccan archaeological and ethnological artifacts, for an additional period.
The US government has reviewed and reaffirmed the designation of several foreign terrorist organizations, including al-Qa'ida in the Indian Subcontinent, Boko Haram, Hizballah, ISIS-West Africa, and Jemaah Islamiyah, as terrorist groups posing a threat to national security.
The IRS has released final regulations updating consolidated return rules and controlled group rules to reflect statutory changes, modernize language, and improve clarity, affecting affiliated corporate groups filing joint tax returns.
The IRS has released proposed regulations that aim to modernize and clarify rules for affiliated corporations filing consolidated tax returns, addressing recent statutory changes and enhancing transparency.
The U.S. government has released final regulations clarifying when tax-exempt bonds issued by state and local governments are considered retired for federal income tax purposes, aiming to unify and simplify existing guidance on the subject.